flâneur

It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough | Jonathan Schott | The Guardian

theguardian.com · 1,224 words · saved by 1 readers

Recent lecanemab trials are reason for hope, although health services may struggle to deliver treatments, says dementia researcher Jonathan Schott

Photograph: Tek/Getty/Science Photo Library RF View image in fullscreen Photograph: Tek/Getty/Science Photo Library RF Opinion Alzheimer's This article is more than 3 years old It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough This article is more than 3 years old Jonathan Schott Recent lecanemab trials are reason for hope. But the NHS and other health services may struggle to deliver these new treatments NHS ‘nowhere near ready’ to deliver new Alzheimer’s drug, doctors say Wed 30 Nov 2022 04.48 EST Last modified on Wed 30 Nov 2022 12.43 EST Share I t is 20 yea

saved by

related reading